文献速递血栓与止血贫血与红细胞疾病

先天性心脏病重症监护室内血小板减少症:发生率、危险因素与结局

Thrombocytopenia developed in intensive care unit for congenital heart disease: incidence, risk factors, and outcomes.
PubMed 文献 · J Thromb Haemost · 2024-06-21

该回顾性研究纳入11761例体外循环下先天性心脏病手术患儿,按ICU血小板计数分为非、轻度、中度、重度血小板减少四组,ICU血小板减少发生率为34.1%,中度和重度血小板减少与30天死亡风险显著升高相关,且血小板减少严重程度增加伴随术后出血、血栓、输血、ICU停留及机械通气时间增加。

要点

  • ICU血小板减少发生于34.1%的体外循环先天性心脏病术后患儿。
  • 中度血小板减少30天死亡HR 11.38(95%CI 3.02-42.87),重度HR 49.54(95%CI 13.11-187.14)。
  • 血小板减少越重,术后严重出血、血栓、输血、ICU停留及机械通气时间增加。

核心结论

  • 体外循环先天性心脏病术后患儿中约三分之一发生ICU血小板减少,且与多种不良结局相关。

研究设计与样本

  • 回顾性研究,纳入11761例体外循环下先天性心脏病手术患儿。
  • 按ICU期间血小板计数分为4组:非血小板减少(>150×10^9/L)、轻度(100-150×10^9/L)、中度(50-100×10^9/L)、重度(<50×10^9/L)。
  • 采用Logistic回归和Cox回归分析血小板减少的危险因素及其与30天死亡率的关联。

主要发现

  • ICU血小板减少见于4007例(34.1%),其中轻度2773例(23.6%)、中度987例(8.4%)、重度247例(2.1%)。
  • 较低年龄、发绀型先天性心脏病、体外循环时长及术前实验室指标(红细胞、血小板减少、红细胞分布宽度、血细胞比容及凝血功能障碍)为ICU血小板减少的独立危险因素。
  • 中度血小板减少患者30天死亡风险HR 11.38(95%CI 3.02-42.87;P < .001),重度HR 49.54(95%CI 13.11-187.14;P < .001)。
  • 随ICU血小板减少严重程度增加,术后严重出血和血栓发生率、围术期输血、ICU停留时间及机械通气时长均递增。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thrombocytopenia is common for patients in the intensive care unit (ICU) and is associated with adverse outcomes. ICU thrombocytopenia in pediatric patients who underwent cardiac surgeries with cardiopulmonary bypass (CPB) is inadequately studied. OBJECTIVES: We aimed to investigate the incidence, risk factors, and prognostic role of ICU thrombocytopenia after congenital cardiac surgeries with CPB. METHODS: A retrospective study involving 11 761 patients was conducted. Patients were categorized into 4 groups of thrombocytopenia based on platelet counts tested during ICU: non (>150 × 109/L), mild (100-150 × 109/L), moderate (50-100 × 109/L), and severe (<50 × 109/L). Logistic and Cox regression analyses were utilized to explore the risk factors of thrombocytopenia and the association of ICU thrombocytopenia with 30-day mortality. RESULTS: ICU thrombocytopenia was observed in 4007 patients (34.1%), with mild, moderate, and severe thrombocytopenia occurring in 2773 (23.6%), 987 (8.4%), and 247 (2.1%) patients, respectively. Younger age, cyanotic congenital heart disease, CPB duration, and preoperative laboratory findings (red blood cell, thrombocytopenia, red cell distribution width, hematocrit, and coagulation disorder) were identified as independent risk factors of ICU thrombocytopenia. Patients with moderate (hazard ratio [95% CI]: 11.38 [3.02-42.87]; P < .001) and severe thrombocytopenia (hazard ratio [95% CI]: 49.54 [13.11-187.14]; P < .001) had a significantly higher risk of 30-day mortality. Furthermore, with the increase in the severity of ICU thrombocytopenia, there was an incremental increase in the incidence of postoperative critical bleeding and thrombosis, perioperative blood transfusions, length of ICU stays, and duration of mechanical ventilation. CONCLUSION: ICU thrombocytopenia occurred in one-third of children after congenital cardiac surgery with CPB, and it was associated with multiple adverse outcomes.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Shen H, He Q, Li W, et al. Thrombocytopenia developed in intensive care unit for congenital heart disease: incidence, risk factors, and outcomes. J Thromb Haemost. 2024. PMID: 38908831. doi:10.1016/j.jtha.2024.05.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。